CHG-2022-0203

Specification Change for Upadacitimab. Specification Change for Upadacitimab — minor update. Impacts 3 markets and 3 variations.

Change Number
CHG-2022-0203
Type
Specification Change
Product
Upadacitimab
Status
Pending
Owner
Nadia Petrova
Initiated
2022-12-22
Description

Specification Change for Upadacitimab — minor update

Impacted Markets (3)
ES — SpainSG — SingaporeRU — Russia
Impacted Modules
2.3.P5.3.54.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved